TEVA-NAPROXEN SODIUM DS
TEVA-NAPROXEN SODIUM DS
Approved
DIN Number
02026600
Drug Class
Human
Market Date
Dec 31, 1993
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02026600
AIG Number0113934002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AE02 NAPROXEN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
NAPROXEN SODIUMActive
Strength: 550 MG
Monograph: NAPROXEN SODIUM